1. Therapeutic drug monitoring of antiarrhythmic agents;Brown, J.E.; Shand, D.G.;Clin Pharmacokinet; Background review of drug monitoring of antiarrhythmics,1982
2. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability;Bryson, S.M.; Whiting, B.; Lawrence, JR;Br J Clin Pharmacol; Emphasises the relation of QT interval to plasma concentrations of disopyramide,1978
3. Long term oral antiarrhythmic therapy with mexiletine;Campbell, N.P.S.; Pantridge, J.F.; Adgey, A.A.J.;Br HeartJ,1977
4. Relation of ventricular premature beat suppression to serum quinidine concentration determined by a new and specific assay;Carliner, N.H.; Fisher, M.L.; Crouthamel, W.G.; Narang, P.K.; Plotnick, G.D.,1980
5. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease;Gianelly, R.; Von der Groeben, J.O.; Spivack, A.P.; Harrison, D.C.;N EnglJ Med,1967